← Back to Clinical Trials
Recruiting Phase 1, Phase 2 NCT06241235
NCT06241235 Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06241235 |
| Status | Recruiting |
| Phase | Phase 1, Phase 2 |
| Sponsor | Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
| Condition | Cervical Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2024-03-27 |
| Primary Completion | 2026-05 |
Trial Parameters
Condition Cervical Carcinoma
Sponsor Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Study Type INTERVENTIONAL
Phase Phase 1, Phase 2
Enrollment 48
Sex FEMALE
Min Age 18 Years
Max Age 70 Years
Start Date 2024-03-27
Completion 2026-05
Interventions
ZG005 Powder for InjectionPaclitaxelBevacizumab
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This is a multicenter, open-label phase I/II study for the first-line treatment of advanced cervical cancer.
Eligibility Criteria
Inclusion Criteria: * Fully understand the study and voluntarily sign the informed consent form. * Female 18-70 years of age; * Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or * Life expectancy ≥ 3 months. Exclusion Criteria: * Patients were deemed unsuitable for participating in the study by the investigator for any reasons.
Related Trials
NCT06241235
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced
View Trial →
NCT06967961
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic
View Trial →
NCT06492070
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Pa
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology